SCHEMBL8781042

SCHEMBL8781042

CCCC(N)c1ccccc1OCc1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.50
▸ HTR1A P08908 2/20 0.50
▸ SLC1A5 Q15758 1/20 0.47
▸ SGMS2 Q8NHU3 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ GCK P35557 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TLR8 Q9NR97 1/20 0.42
▸ TLR7 Q9NYK1 1/20 0.42
▸ IKBKB O14920 1/20 0.42
▸ HTR6 P50406 1/20 0.41
▸ GPR132 Q9UNW8 3/20 0.41
▸ LTA4H P09960 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ AOC3 Q16853 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8781095 0.85 ABCB1 (0.46) HTR1ASGMS2ALDH1A1LMNAIKBKB
SCHEMBL806892 0.81 HTR1A (0.57) DRD2HTR1ASLC1A5SGMS2ALDH1A1
SCHEMBL8781006 0.77 SYK (0.47) DRD2HTR1ASLC1A5CYP1A2GCK
SCHEMBL2652374 0.77 ALDH1A1 (0.50) CYP1A2ALDH1A1POLB
SCHEMBL9460724 0.73 HTR1A (0.53) DRD2HTR1ASGMS2CYP1A2ALDH1A1
SCHEMBL21465845 0.73 HTR1A (0.61) DRD2HTR1ASLC1A5SGMS2ALDH1A1
SCHEMBL1028598 0.73 HTR1A (0.61) DRD2HTR1ASLC1A5SGMS2CYP1A2
SCHEMBL8130463 0.73 HTR1A (0.61) DRD2HTR1ASLC1A5SGMS2ALDH1A1
SCHEMBL15084393 0.73 HTR1A (0.61) DRD2HTR1AALDH1A1POLBGCK
Hydrochloric Acid SCHEMBL9461010 0.72 HTR1A (0.51) DRD2HTR1ASGMS2CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 — — EP disclosed
Send feedback